Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      Join PfizerLink — a clinical research registry

      Get notified about clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit.

      Sign up

      Sickle Cell Disease clinical trial

      The DREAM study is exploring whether a study medicine can reduce symptoms and improve the overall health of people with Sickle Cell Disease.

      Get started

      Join a COVID-flu vaccine clinical trial near you

      We’re working closely with doctors and scientists to conduct a clinical trial of combined COVID-19 and flu vaccines. See if you qualify.

      Learn more

      203 trials found

      All(203)
      Recruiting(176)
      Not yet recruiting(27)
      Recruiting
      NCT04609566
      Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

      Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck

      Male or Female
      18+ years
      25study location(s)
      Recruiting
      NCT06003231
      A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

      Carcinoma, Squamous Cell of Head and Neck, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms

      Male or Female
      18+ years
      20study location(s)
      Recruiting
      NCT06254495
      A Safety Study of SGN-35C in Adults With Advanced Cancers

      Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

      Male or Female
      18+ years
      1study location(s)
      Recruiting
      NCT05911295
      Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

      Urothelial Carcinoma

      Male or Female
      18+ years
      32study location(s)
      Recruiting
      NCT05926960
      A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma

      Melanoma

      Male or Female
      18+ years
      59study location(s)
      Recruiting
      NCT04430738
      Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

      Colorectal Carcinoma, Gastric Adenocarcinoma, GEJ Adenocarcinoma, Esophageal Adenocarcinoma, Cholangiocarcinoma, Gallbladder Carcinoma

      Male or Female
      18+ years
      7study location(s)
      Recruiting
      NCT06131840
      A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

      Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Pancreatic Ductal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Small Cell Lung Carcinoma

      Male or Female
      18+ years
      9study location(s)
      Recruiting
      NCT04693351
      Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder

      Obsessive-Compulsive Disorder

      Male or Female
      18 - 65 years
      77study location(s)
      Recruiting
      NCT04641143
      Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

      Obsessive-Compulsive Disorder

      Male or Female
      18 - 65 years
      50study location(s)
      Recruiting
      NCT06132893
      A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

      Focal Epilepsy

      Male or Female
      18 - 75 years
      51study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(203)
      Recruiting(176)
      Not yet recruiting(27)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.